This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
CRAI vs. ACN: Which Stock Is the Better Value Option?
by Zacks Equity Research
CRAI vs. ACN: Which Stock Is the Better Value Option?
Accenture (ACN) Announces the Completion of N3 Acquisition
by Zacks Equity Research
Accenture (ACN) is now in a position to aggregate millions of interaction points into actionable insights by combining its SynOps platform with N3's cloud-based AI/ML technology.
Duke Energy Plans to Expand EV Charging in South Carolina
by Zacks Equity Research
Duke Energy (DUK) will install and operate 60 fast chargers across Duke Energy Carolinas and Duke Energy Progress South Carolina territories.
Accenture Unveils Net-Zero Emission, Waste and Water Goals
by Zacks Equity Research
The efforts are part of Accenture's (ACN) endeavors to reduce its environmental impact and establish responsible business practices.
Science Applications Secures U.S. Navy Contract Worth $49.5M
by Zacks Equity Research
Science Applications (SAIC) will provide its support services to the Royal Saudi Naval Forces for upgradation and refurbishment of control, command, communications, intelligence and surveillance.
Accenture (ACN) to Gain From Avenai Acquisition: Here's How
by Zacks Equity Research
The latest deal is expected to help Accenture (ACN) strengthen its competitive position in the public sector market in Canada.
Infosys (INFY) to Enhance Mobile Health's Go-To-Market Strategy
by Zacks Equity Research
Infosys' (INFY) digital technologies to help Swiss health-tech start-up Mobile Health AG launch and enhance the go-to-market strategy for the latter's Consilium Care ePRO platform.
Accenture to Gain From Myrtle Consulting Buyout: Here's How
by Zacks Equity Research
The acquisition is likely to help Accenture (ACN) strengthen its digital manufacturing, operations and supply-chain capabilities.
Accenture (ACN) Gains on Strong Balance Sheet & Acquisitions
by Zacks Equity Research
Accenture (ACN) is benefiting from a strong outsourcing business. However, higher talent cost remains a concern for the company.
Timing the Market, Is it Possible? - September 28, 2020
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
Top Analyst Reports for P&G, Verizon & Thermo Fisher
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Procter & Gamble (PG), Verizon Communications (VZ) and Thermo Fisher Scientific (TMO).
NVEE vs. ACN: Which Stock Is the Better Value Option?
by Zacks Equity Research
NVEE vs. ACN: Which Stock Is the Better Value Option?
Company News for Sep 25, 2020
by Zacks Equity Research
Companies in the news are: DRI, ACN, JBL, FDS
Accenture's (ACN) Q4 Earnings & Revenues Miss Estimates
by Zacks Equity Research
Accenture's (ACN) fourth-quarter fiscal 2020 earnings and revenues decrease on a year-over-year basis.
Accenture Proclaims Project on Pediatric Leukemia Research
by Zacks Equity Research
Built on Accenture (ACN) research, the approach offers a more informed assessment of clinical and genomic data.
Accenture (ACN) Lags Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Accenture (ACN) delivered earnings and revenue surprises of -2.30% and -0.67%, respectively, for the quarter ended August 2020. Do the numbers hold clues to what lies ahead for the stock?
Accenture (ACN) to Benefit From N3 Acquisition: Here's How
by Zacks Equity Research
The acquisition is expected to complement Accenture's (ACN) existing artificial intelligence and machine-learning capabilities.
Is a Beat in the Cards for Accenture (ACN) in Q4 Earnings?
by Zacks Equity Research
Accenture's (ACN) fourth-quarter fiscal 2020 revenues are expected to have declined year over year.
Why the Earnings Surprise Streak Could Continue for Accenture (ACN)
by Zacks Equity Research
Accenture (ACN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Analysts Estimate Accenture (ACN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Accenture (ACN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Accenture (ACN) to Snap Up German Technology Consultancy
by Zacks Equity Research
The buyout complements Accenture's (ACN) capabilities in enterprise resource-planning systems and cloud solutions.
Here's Why You Should Hold Accenture (ACN) in Your Portfolio
by Zacks Equity Research
Acquisitions are one of the key growth strategies for Accenture (ACN).
NVEE or ACN: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
NVEE vs. ACN: Which Stock Is the Better Value Option?
Accenture to Use InCountry's Solution in Its Cloud Platform
by Zacks Equity Research
The move is part of Accenture's (ACN) continuous efforts to invest in emerging technologies capable of creating value for the company's clients across the world.
Accenture Announces Sale of Stake in Its Bit2win Business
by Zacks Equity Research
Bit2win's senior management team, along with 25 personnel, is expected to move from Accenture (ACN) to the new company.